Suzuki Ayana, Hirokawa Mitsuyoshi, Takada Nami, Higuchi Miyoko, Ito Aki, Yamao Naoki, Hayashi Toshitetsu, Kuma Seiji, Miyauchi Akira
Department of Clinical Laboratory, Kuma Hospital, Kobe, Japan.
Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan.
Endocr J. 2017 Nov 29;64(11):1099-1104. doi: 10.1507/endocrj.EJ17-0238. Epub 2017 Sep 5.
Many cytological studies on medullary thyroid carcinoma (MTC) have been reported; however, such studies in large series of patients with MTC have not been performed. We investigated MTC at a single institution in Japan using fine-needle aspiration cytology (FNAC), and aimed to establish a preoperative diagnostic algorithm for MTC. FNAC was performed in 119 of 149 patients with MTC (79.9%) who ultimately underwent surgical resection. Moreover, 22 of 56 hereditary MTC (39.3%) were diagnosed preoperatively without FNAC by their high serum calcitonin levels or increased response to calcium stimulation (11 cases each), as well as RET mutation analysis. On FNAC, 76.5% of nodules were categorized as 'malignancy' or 'suspicious for malignancy'. The sensitivity and specificity of calcitonin measurement in aspiration needle wash-out fluid and in immunocytochemical staining for calcitonin were 96.3% and 92.3% respectively. We proposed an algorithm for preoperative diagnosis of MTC utilizing FNAC: When thyroid nodules are highly suspicious for MTC by their clinical and ultrasonographic features, serum calcitonin measurement with or without a calcium stimulation test is required. Furthermore, FNAC should be performed for patients who do not have those findings. When there is a possibility of MTC at the time of FNAC, calcitonin measurement using needle wash-out fluid is a reliable diagnostic tool. When MTC is suspected on cytological examination, immunocytochemical staining for calcitonin is useful for confirming MTC diagnosis.
关于甲状腺髓样癌(MTC)的许多细胞学研究已有报道;然而,尚未对大量MTC患者进行此类研究。我们在日本的一家机构使用细针穿刺细胞学检查(FNAC)对MTC进行了研究,旨在建立MTC的术前诊断算法。149例最终接受手术切除的MTC患者中有119例(79.9%)进行了FNAC。此外,56例遗传性MTC中有22例(39.3%)术前通过高血清降钙素水平或对钙刺激的反应增强(各11例)以及RET突变分析得以诊断,未进行FNAC。在FNAC检查中,76.5%的结节被归类为“恶性”或“可疑恶性”。穿刺针冲洗液中降钙素测量以及降钙素免疫细胞化学染色的敏感性和特异性分别为96.3%和92.3%。我们提出了一种利用FNAC进行MTC术前诊断的算法:当甲状腺结节根据其临床和超声特征高度可疑为MTC时,需要进行血清降钙素测量,可进行或不进行钙刺激试验。此外,对于没有这些表现的患者应进行FNAC。当FNAC时存在MTC的可能性时,使用穿刺针冲洗液进行降钙素测量是一种可靠的诊断工具。当细胞学检查怀疑为MTC时,降钙素免疫细胞化学染色有助于确诊MTC。